Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
100 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The U.S. hospice market size is expected to reach USD 53.2 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.3% over the forecast period. Rising healthcare expenditure, awareness about the benefits of the hospices, and favorable reimbursements are some of the major growth drivers. According to the U.S. Centers for Medicare & Medicaid Services, the U.S. healthcare spending increased by 4.6% and reached USD 3.5 trillion in 2017. It is projected to reach USD 6.0 trillion by 2026. According to the Centers for Disease Control and Prevention (CDC), the number of hospice care agencies in U.S. reached 4,500 by 2018 from 4,300 in 2016. According to the Hospice Demographic and Outcome Measures Report, the percentage of accredited hospices reached 63% in 2017. In addition, a substantial growth in the use of these benefits among the Medicare beneficiaries is anticipated to boost the market growth. According to the National Hospice and Palliative Care Organization, in 2017, USD 18 billion were spent by Medicare on hospice services. Rising demand for remote patient monitoring coupled with technological advancements, such as tele hospice are anticipated to drive the U.S. hospice market in near future. Approximately 10,000 physicians are required in hospice and palliative care in U.S. Telemedicine technology is an ideal alternative to reduce this gap. Videoconferences with the help of laptops and iPads help physicians to offer optimal support and advice to caregivers or patients doubtful for treatment in emergency cases. Further key findings from the report suggest: • By location, hospice center segment held the maximum market share in 2018 since it prevents the need for hospitalization and offers a more balanced and controlled care settings • Home hospice care is anticipated to be the fastest-growing segment during the forecast period due to comfortable environment to the patient, favorable reimbursement, with constant care provided to the patient • Routine home care segment accounted for the largest market share in 2018 owing to the factors, such as increased medical coverage, low cost of care, along with the access to quality care, companionship, family involvement, and constant attention to the patients • Dementia segment dominated the U.S. hospice market in 2018 due to high prevalence and need for the care driven by increased mental impairment and dependency • Few of the key market players include Kindred Healthcare, Inc.; Chemed Corporation; Amedisys, Inc.; LHC Group Inc.; Brookdale Senior Living Solutions; Senior Care Health Rehabilitation; Seasons Hospice & Palliative Care; Crossroads Hospice; AccentCare; and Curo Health Services
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Type
1.1.2 Location
1.1.3 Diagnosis
1.1.4 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.2 Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type
2.2.2 Location
2.2.3 Diagnosis
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.3.1 Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising geriatric population
3.4.1.2 Rising medicare spending on post-acute-care
3.4.1.3 Increasing prevalence of multiple chronic conditions
3.4.2 Market Restraint Analysis
3.4.2.1 Regulatory compliance
3.4.2.2 Inadequate workforce
3.5 Business Environment Analysis Tools
3.5.1 PESTEL Analysis
3.6 Porter's Five Forces Analysis
3.6.1 Porter's Five Forces Analysis
3.7 U.S. Hospice Market: Pricing Analysis
3.8 Regulatory Framework & Reimbursement: U.S. Hospice Market, 2018
3.8.1 Regulatory Framework
3.8.2 Reimbursement Scenario
Chapter 4 U.S. Hospice Market: Type Analysis
4.1 U.S. Hospice Market Share Analysis, 2018 & 2026
4.2 Segment Dashboard
4.3 U.S. Hospice Market, 2018 to 2026
4.4 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Hospice Type
4.4.1 Routine Homecare
4.4.1.1 Routine homecare market, 2015 - 2026 (USD Million)
4.4.2 Continuous Homecare
4.4.2.1 Continuous homecare market, 2015 - 2026 (USD Million)
4.4.3 Inpatient Respite Care
4.4.3.1 Inpatient respite care market, 2015 - 2026 (USD Million)
4.4.4 General Inpatient Care
4.4.4.1 General inpatient care market, 2015 - 2026 (USD Million)
Chapter 5 U.S. Hospice Market: Location Analysis
5.1 U.S. Hospice by Location Market Share Analysis, 2018 & 2026
5.2 Segment Dashboard
5.3 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Location
5.3.1 Hospice Center
5.3.1.1 Hospice center market, 2015 - 2026 (USD Million)
5.3.2 Hospital
5.3.2.1 Hospital market, 2015 - 2026 (USD Million)
5.3.3 Home Hospice Care
5.3.3.1 Home hospice care market, 2015 - 2026 (USD Million)
5.3.4 Skilled Nursing Facility
5.3.4.1 Skilled nursing facility market, 2015 - 2026 (USD Million)
Chapter 6 U.S. Hospice Market: Diagnosis Analysis
6.1 U.S. Hospice by Diagnosis Market Share Analysis, 2018 & 2026
6.2 Segment Dashboard
6.3 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the Diagnosis
6.3.1 Dementia
6.3.1.1 Dementia market, 2015 - 2026 (USD Million)
6.3.2 Circulatory/Heart
6.3.2.1 Circulatory/heart market, 2015 - 2026 (USD Million)
6.3.3 Cancer
6.3.3.1 Cancer market, 2015 - 2026 (USD Million)
6.3.4 Respiratory
6.3.4.1 Respiratory market, 2015 - 2026 (USD Million)
6.3.5 Stroke
6.3.5.1 Stroke market, 2015 - 2026 (USD Million)
6.3.6 Chronic Kidney Disease
6.3.6.1 Chronic kidney disease market, 2015 - 2026 (USD Million)
6.3.7 Others
6.3.7.1 Others market, 2015 - 2026 (USD Million)
Chapter 7 Competitive Analysis
7.1 Strategic Framework
7.2 Vendor Landscape
7.2.1 Product Launches
7.2.2 Mergers & Acquisitions
7.2.3 Partnerships
7.3 Competitive Landscape: Market Position Analysis
7.3.1 Competitive Landscape: Market Position Analysis (Based On Services, Regional Presence, and Strategic Initiatives)
7.4 Company Profiles
7.4.1 CHEMED CORPORATION
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Product benchmarking
7.4.1.4 Strategic initiatives
7.4.2 KINDRED Healthcare, INC.
7.4.2.1 Company overview
7.4.2.2 Financial performance
7.4.2.3 Product benchmarking
7.4.2.4 Strategic initiatives
7.4.3 Amedisys, INC.
7.4.3.1 Company overview
7.4.3.2 Financial performance
7.4.3.3 Product benchmarking
7.4.3.4 Strategic initiatives
7.4.4 LHC Group Inc.
7.4.4.1 Company overview
7.4.4.2 Financial performance
7.4.4.3 Product benchmarking
7.4.4.4 Strategic initiatives
7.4.5 Brookdale Senior Living Solutions
7.4.5.1 Company overview
7.4.5.2 Financial performace
7.4.5.3 Product benchmarking
7.4.5.4 Strategic initiatives
7.4.6 Senior Care Health Rehabilitation
7.4.6.1 Company overview
7.4.6.2 Product benchmarking
7.4.6.3 Strategic initiatives
7.4.7 Seasons Hospice & Palliative Care
7.4.7.1 Company overview
7.4.7.2 Product benchmarking
7.4.7.3 Strategic initiatives
7.4.8 Crossroads Hospice
7.4.8.1 Company overview
7.4.8.2 Product benchmarking
7.4.8.3 Strategic initiatives
7.4.9 AccentCare
7.4.9.1 Company overview
7.4.9.2 Product benchmarking
7.4.9.3 Strategic initiatives
7.4.10 Curo Health Services.
7.4.10.1 Company overview
7.4.10.2 Product benchmarking
7.4.10.3 Strategic initiatives
7.4.11 Compassus
7.4.11.1 Company overview
7.4.11.2 Product benchmarking
7.4.11.3 Strategic initiatives
7.4.12 Hospice of the Valley
7.4.12.1 Company overview
7.4.12.2 Product benchmarking
7.4.12.3 Strategic initiatives
7.4.13 Providence Health & Services
7.4.13.1 Company overview
7.4.13.2 Product benchmarking
7.4.13.3 Strategic initiatives
7.4.14 AseraCare Hospice
7.4.14.1 Company overview
7.4.14.2 Product benchmarking
7.4.14.3 Strategic initiatives
7.4.15 TIDEWELL HOSPICE
7.4.15.1 Company overview
7.4.15.2 Product benchmarking
7.4.15.3 Strategic initiatives
7.4.16 Heart to Heart Hospice
7.4.16.1 Company overview
7.4.16.2 Product benchmarking
7.4.16.3 Strategic initiatives
7.4.17 Oklahoma Palliative & Hospice Care
7.4.17.1 Company overview
7.4.17.2 Product benchmarking
7.4.17.3 Strategic initiatives
7.4.18 Covenant Care
7.4.18.1 Company overview
7.4.18.2 Product benchmarking
7.4.18.3 Strategic initiatives
7.4.19 Dierksen Hospice
7.4.19.1 Company overview
7.4.19.2 Product benchmarking
7.4.19.3 Strategic initiatives
7.4.20 Fairview Health
7.4.20.1 Company overview
7.4.20.2 Product benchmarking
7.4.20.3 Strategic initiatives
List of Tables TABLE 1 List of secondary sources TABLE 2 List of abbreviations TABLE 3 Incidence of cardiovascular diseases in older Americans TABLE 4 Services and costs TABLE 5 State-wise Medicare Certified Hospices by Amedisys TABLE 6 Recently launched products TABLE 7 Recent mergers & acquisitions
List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value chain-based sizing & forecasting Fig. 6 QFD modeling for market share assessment Fig. 7 Market formulation & validation Fig. 8 Market outlook Fig. 9 U.S. hospice market segmentation Fig. 10 Penetration & growth prospect mapping Fig. 11 Market trends & outlook Fig. 12 Market driver relevance analysis (Current & future impact) Fig. 13 Market restraint relevance analysis (Current & future impact) Fig. 14 PESTLE analysis Fig. 15 Porter's five forces analysis Fig. 16 U.S. Hospice market: Type movement analysis, 2018 & 2026 Fig. 17 U.S. Hospice market type outlook: Key takeaways Fig. 18 U.S. Hospice market, 2015 - 2026 (USD Million) Fig. 19 Routine homecare market, 2015 - 2026 (USD Million) Fig. 20 Continuous homecare market, 2015 - 2026 (USD Million) Fig. 21 Inpatient respite care market, 2015 - 2026 (USD Million) Fig. 22 General inpatient care market, 2015 - 2026 (USD Million) Fig. 23 U.S. Hospice market: Location movement analysis Fig. 24 Hospice location outlook: Key takeaways Fig. 25 Hospice center market, 2015 - 2026 (USD Million) Fig. 26 Hospital market 2015 - 2026 (USD Million) Fig. 27 Home hospice care market 2015 - 2026 (USD Million) Fig. 28 Skilled nursing facility market 2015 - 2026 (USD Million) Fig. 29 U.S. Hospice market: Diagnosis movement analysis Fig. 30 Hospice diagnosis outlook: Key takeaways Fig. 31 Dementia market, 2015 - 2026 (USD Million) Fig. 32 Circulatory/heart market 2015 - 2026 (USD Million) Fig. 33 Cancer market 2015 - 2026 (USD Million) Fig. 34 Respiratory market 2015 - 2026 (USD Million) Fig. 35 Stroke market 2015 - 2026 (USD Million) Fig. 36 Chronic kidney disease market 2015 - 2026 (USD Million) Fig. 37 Others market 2015 - 2026 (USD Million) Fig. 38 Strategy framework Fig. 39 Heat map analysis
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
